|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
EP0173494A3
(en)
|
1984-08-27 |
1987-11-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric receptors by dna splicing and expression
|
|
US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
|
JPS63501765A
(ja)
|
1985-11-01 |
1988-07-21 |
インタ−ナショナル、ジェネティック、エンジニアリング インコ−ポレ−テッド |
抗体遺伝子のモジュ−ル組立体、それにより産生された抗体及び用途
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5132405A
(en)
|
1987-05-21 |
1992-07-21 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
|
US5010175A
(en)
|
1988-05-02 |
1991-04-23 |
The Regents Of The University Of California |
General method for producing and selecting peptides with specific properties
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
IL162181A
(en)
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
IE66205B1
(en)
|
1990-06-14 |
1995-12-13 |
Paul A Bartlett |
Polypeptide analogs
|
|
US5650489A
(en)
|
1990-07-02 |
1997-07-22 |
The Arizona Board Of Regents |
Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
|
|
US5527679A
(en)
|
1991-05-01 |
1996-06-18 |
Dana Farber Cancer Institute |
β5 protein and DNA encoding the same
|
|
DE4142366A1
(de)
|
1991-07-15 |
1993-06-24 |
Thomae Gmbh Dr K |
Phenylalkylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
DE4123341A1
(de)
|
1991-07-15 |
1993-01-21 |
Thomae Gmbh Dr K |
Phenylalkylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
US5777085A
(en)
|
1991-12-20 |
1998-07-07 |
Protein Design Labs, Inc. |
Humanized antibodies reactive with GPIIB/IIIA
|
|
US6291196B1
(en)
|
1992-01-31 |
2001-09-18 |
Research Corporation Technologies, Inc. |
Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy
|
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
|
US5288514A
(en)
|
1992-09-14 |
1994-02-22 |
The Regents Of The University Of California |
Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
|
|
US6210671B1
(en)
|
1992-12-01 |
2001-04-03 |
Protein Design Labs, Inc. |
Humanized antibodies reactive with L-selectin
|
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
|
US5593853A
(en)
|
1994-02-09 |
1997-01-14 |
Martek Corporation |
Generation and screening of synthetic drug libraries
|
|
US5539083A
(en)
|
1994-02-23 |
1996-07-23 |
Isis Pharmaceuticals, Inc. |
Peptide nucleic acid combinatorial libraries and improved methods of synthesis
|
|
US5525735A
(en)
|
1994-06-22 |
1996-06-11 |
Affymax Technologies Nv |
Methods for synthesizing diverse collections of pyrrolidine compounds
|
|
US5549974A
(en)
|
1994-06-23 |
1996-08-27 |
Affymax Technologies Nv |
Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof
|
|
US5780426A
(en)
|
1995-06-07 |
1998-07-14 |
Ixsys, Incorporated |
Fivemer cyclic peptide inhibitors of diseases involving αv β3
|
|
US5569588A
(en)
|
1995-08-09 |
1996-10-29 |
The Regents Of The University Of California |
Methods for drug screening
|
|
US7053041B1
(en)
|
1996-05-31 |
2006-05-30 |
The Scripps Research Institute |
Methods and compositions useful for inhibition of αvβ5mediated angiogenesis
|
|
UA60311C2
(uk)
|
1996-10-02 |
2003-10-15 |
Смітклайн Бічам Корпорейшн |
Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція
|
|
CO4920232A1
(es)
|
1997-01-08 |
2000-05-29 |
Smithkline Beecham Corp |
Acidos aceticos dibenzo [a,d] cicloheptano con actividad antagonista del receptor de vitronectin
|
|
TW589189B
(en)
|
1997-08-04 |
2004-06-01 |
Scras |
Kit containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease, notably of viral hepatitis
|
|
EE04752B1
(et)
|
1997-08-08 |
2006-12-15 |
The Regents Of The University Of California |
Monoklonaalne antikeha, seda tootev hübridoom ja antikeha kasutamine
|
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
AUPP249298A0
(en)
|
1998-03-20 |
1998-04-23 |
Ag-Gene Australia Limited |
Synthetic genes and genetic constructs comprising same I
|
|
GB9827152D0
(en)
|
1998-07-03 |
1999-02-03 |
Devgen Nv |
Characterisation of gene function using double stranded rna inhibition
|
|
DE19842415A1
(de)
|
1998-09-16 |
2000-03-23 |
Merck Patent Gmbh |
Pharmazeutische Zubereitung
|
|
JP2002531466A
(ja)
|
1998-12-01 |
2002-09-24 |
プロテイン デザイン ラブス， インコーポレイテッド |
γ−インターフェロンに対するヒト化抗体
|
|
EP2314700A1
(en)
|
1999-01-28 |
2011-04-27 |
Medical College of Georgia Research Institute, Inc |
Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA
|
|
DE19956568A1
(de)
|
1999-01-30 |
2000-08-17 |
Roland Kreutzer |
Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
|
|
CA2352957A1
(en)
|
1999-09-29 |
2001-04-05 |
Ortho-Mcneil Pharmaceutical, Inc. |
Isonipecotamides for the treatment of integrin-mediated disorders
|
|
CA2386270A1
(en)
|
1999-10-15 |
2001-04-26 |
University Of Massachusetts |
Rna interference pathway genes as tools for targeted genetic interference
|
|
GB9927444D0
(en)
|
1999-11-19 |
2000-01-19 |
Cancer Res Campaign Tech |
Inhibiting gene expression
|
|
CA2397194C
(en)
|
2000-01-20 |
2011-05-17 |
Mark E. Duggan |
Alpha v integrin receptor antagonists
|
|
EP1254116A4
(en)
|
2000-01-24 |
2003-04-23 |
Merck & Co Inc |
ALPHA V INTEGRIN RECEPTOR ANTAGONISTS
|
|
WO2001056607A1
(en)
|
2000-02-03 |
2001-08-09 |
Eisai Co., Ltd. |
Integrin expression inhibitors
|
|
AU2001259078A1
(en)
|
2000-04-18 |
2001-10-30 |
Edema Clearance, Inc. |
Gene theraphy for pulmonary edema using adenovirus vectors encoding a beta2adrenergic receptor gene
|
|
UY26780A1
(es)
|
2000-06-15 |
2002-01-31 |
Pharmacia Corp |
Cicloalquil avb3 antagonistas
|
|
US7288390B2
(en)
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
|
US7163681B2
(en)
*
|
2000-08-07 |
2007-01-16 |
Centocor, Inc. |
Anti-integrin antibodies, compositions, methods and uses
|
|
DE10041423A1
(de)
|
2000-08-23 |
2002-03-07 |
Merck Patent Gmbh |
Biphenylderivate
|
|
US20020072500A1
(en)
|
2000-09-27 |
2002-06-13 |
Thomas Rogers |
Hydroxy acid integrin antagonists
|
|
JP2004513953A
(ja)
|
2000-10-24 |
2004-05-13 |
メルク エンド カムパニー インコーポレーテッド |
ジベンズオキサゼピンαＶインテグリン受容体アンタゴニスト
|
|
JP2004532616A
(ja)
|
2000-12-28 |
2004-10-28 |
ジョンソン・アンド・ジョンソン・リサーチ・ピー・ティー・ワイ・リミテッド |
二本鎖ｒｎａ仲介遺伝子抑制
|
|
EP1393075A4
(en)
|
2001-04-04 |
2006-06-14 |
Allergan Inc |
METHODS OF SCREENING AND USE OF ANGIOGENESIS INHIBITORS
|
|
DE60208186T2
(de)
|
2001-04-09 |
2006-08-24 |
Ortho-Mcneil Pharmaceutical Research Inc. |
Chinazolin- und chinazolinähnliche verbindungen zur behandlung von integrin-vermittelten erkrankungen
|
|
US20040019206A1
(en)
|
2001-09-27 |
2004-01-29 |
Peter Ruminiski |
Lactone integrin antagonists
|
|
US7923454B2
(en)
|
2002-05-17 |
2011-04-12 |
Jenken Biosciences, Inc. |
Opioid and opioid-like compounds and uses thereof
|
|
DK1539739T3
(da)
|
2002-08-16 |
2011-03-07 |
Janssen Pharmaceutica Nv |
Piperidinylforbindelser, der selektivt binder integriner
|
|
ES2671522T3
(es)
*
|
2004-04-02 |
2018-06-06 |
The Regents Of The University Of California |
Métodos y composiciones para tratar y prevenir una enfermedad asociada con la integrina alfa V beta 5
|
|
US20120129757A1
(en)
*
|
2008-12-12 |
2012-05-24 |
Dean Li |
Compositions and methods for promoting vascular barrier function and treating pulonary fibrosis
|
|
JO3421B1
(ar)
|
2011-06-20 |
2019-10-20 |
H Lundbeck As |
طريقة لإعطاء 1-((1ار.3س)-6-كلورو-3-فينيل-اندان-1-ايل)-1.2.2-ترايميثيل- بيبيرازين واملاجها لمعالجة انفصام الشخصية
|
|
HK1219740A1
(zh)
*
|
2013-03-15 |
2017-04-13 |
Biogen Ma Inc. |
使用抗αVβ5抗体治疗和预防急性肾损伤
|
|
MA40536A
(fr)
*
|
2014-09-12 |
2016-03-17 |
Biogen Ma Inc |
Anticorps anti-alpha v bêta 5 humanisés et leurs utilisations
|